T
INSM icon

TOBAM’s Insmed INSM Stock Holding History

TOBAM’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Buy
22,370
+58
+0.3% +$7.02K 0.58% 56
2026
Q1 		$3.65M Buy
22,312
+6,004
+37% +$923K 0.95% 40
2025
Q4 		$2.84M Sell
16,308
-2,789
-15% -$509K 0.7% 46
2025
Q3 		$2.75M Buy
+19,097
New +$2.34M 1% 36
2025
Q1 		– Sell
-4,643
Closed -$321K – 293
2024
Q4 		$321K Sell
4,643
-1,717
-27% -$124K 0.1% 134
2024
Q3 		$464K Buy
+6,360
New +$469K 0.08% 121

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

TOBAM's INSM Position: Q2 2026 in Review

TOBAM increased its Insmed (INSM) stake by 0.26% in Q2 2026, buying an estimated $7.02K and bringing the position to 22,370 shares worth $2.38M. The position accounts for 0.58% of the portfolio, ranked #56.

TOBAM first reported a position in INSM in Q3 2024 and has held it in 6 quarters since. The position peaked at $3.65M in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • TOBAM held 22,370 shares of Insmed worth $2.38M as of Q2 2026.
  • TOBAM bought 58 Insmed shares in Q2 2026, an estimated $7.02K.
  • Insmed made up 0.58% of TOBAM's portfolio in Q2 2026, its #56 holding.
  • TOBAM first reported a position in Insmed in Q3 2024 and has held it in 6 quarters since.
  • TOBAM's Insmed position peaked at $3.65M in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.